Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hewitt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of MS Care|November 16, 2023
Striving to Limit the Impact: Parenting an Adult Child Who Has Multiple Sclerosis-A Grounded Theory StudyCamilla Holden, Peter Hewitt, Rachel Tams
ANZ Journal of Surgery|March 29, 2003
Dressing size and pain: a prospective trialNathan Lawrentschuk, Michael Pritchard, Peter Hewitt, et al.
ANZ Journal of Surgery|January 18, 2008
Risk factors for type II endoleaks after endovascular repair of abdominal aortic aneurysmsRanjana Warrier, Robert Miller, Rick Bond, et al.
Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of MS Care|November 16, 2023
Striving to Limit the Impact: Parenting an Adult Child Who Has Multiple Sclerosis-A Grounded Theory StudyCamilla Holden, Peter Hewitt, Rachel Tams
ANZ Journal of Surgery|March 29, 2003
Dressing size and pain: a prospective trialNathan Lawrentschuk, Michael Pritchard, Peter Hewitt, et al.
ANZ Journal of Surgery|January 18, 2008
Risk factors for type II endoleaks after endovascular repair of abdominal aortic aneurysmsRanjana Warrier, Robert Miller, Rick Bond, et al.
Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.
Pageof 1